Majedie Asset Management’s Boston Scientific BSX Stock Holding History

Majedie Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-66,199	Closed	-$2.87M	–	85
2021 Q3	$2.87M	Sell	66,199 -133,766	-67%	-$5.92M	0.22%	76
2021 Q2	$8.55M	Sell	199,965 -17,622	-8%	-$741K	0.56%	62
2021 Q1	$8.41M	Sell	217,587 -2,968,154	-93%	-$112M	0.61%	54
2020 Q4	$115M	Sell	3,185,741 -1,834,275	-37%	-$66.1M	8.78%	1
2020 Q3	$192M	Sell	5,020,016 -211,972	-4%	-$8.17M	14.28%	2
2020 Q2	$184M	Buy	5,231,988 +1,354,745	+35%	+$48.8M	14.04%	2
2020 Q1	$127M	Buy	+3,877,243	New	+$151M	11.72%	2

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Majedie Asset Management's BSX Position: Q4 2021 in Review

Majedie Asset Management sold out of Boston Scientific (BSX) in Q4 2021, closing a stake of 66,199 shares — an estimated $2.87M sold.

Majedie Asset Management first reported a position in BSX in Q1 2020 and held it in 7 quarters. The position peaked at $192M in Q3 2020. 888 funds tracked by Wall St. Rank hold BSX as of Q4 2021.

Majedie Asset Management reported no remaining Boston Scientific position as of Q4 2021 after selling out during the quarter.
Majedie Asset Management sold 66,199 Boston Scientific shares in Q4 2021, an estimated $2.87M.
Majedie Asset Management first reported a position in Boston Scientific in Q1 2020 and held it in 7 quarters.
Majedie Asset Management's Boston Scientific position peaked at $192M in Q3 2020.
888 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2021.

Based on Majedie Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.